Moody Lynn & Lieberson LLC cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 16.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,895 shares of the biotechnology company’s stock after selling 1,520 shares during the quarter. Moody Lynn & Lieberson LLC’s holdings in Axon Enterprise were worth $4,692,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of AXON. Quent Capital LLC lifted its holdings in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. Brooklyn Investment Group bought a new position in shares of Axon Enterprise during the 3rd quarter valued at about $41,000. Planning Capital Management Corp grew its position in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new stake in Axon Enterprise during the 3rd quarter worth approximately $51,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Analyst Upgrades and Downgrades
AXON has been the subject of several research analyst reports. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $504.92.
Axon Enterprise Stock Down 0.5 %
AXON stock opened at $610.32 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $247.04 and a fifty-two week high of $698.67. The stock has a fifty day moving average of $617.65 and a 200-day moving average of $470.75. The company has a market capitalization of $46.54 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Insider Activity
In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by corporate insiders.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Bloom Energy: Powering the Future With Decentralized Energy
- Stock Analyst Ratings and Canadian Analyst Ratings
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.